All In Biotech

Drug Trial Radar · NCT00520286

Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence

Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence

Last checked: Nov 19, 2026Latest source record: Apr 7, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 210 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

210

Actual

Start

Dec 2007

Primary completion

Dec 2009

Study completion Mar 2010

Sponsor

Sponsor type
NIH
Collaborators
VA Office of Research and Development
First posted
Aug 24, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study will be to examine the safety and efficacy of modafinil in increasing number of methamphetamine non-use weeks in subjects with methamphetamine dependence.

Conditions

  • Methamphetamine Dependence

Interventions

  • ModafinilDrug

    200 mg or 400 mg /daily

  • PlaceboDrug

    Placebo / daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Abstinence (Week 1 - 12)Time frame: Weeks 1 - 12

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • South Bay Treatment Center

    San Diego, California

  • Matrix Institute on Addictions

    Tarzana, California

  • Torrance Site

    Torrance, California

  • University of Colorado Health Sciences Center

    Denver, Colorado

  • John A. Burns School of Medicine

    Honolulu, Hawaii

  • Powell Chemical Dependency Center

    Des Moines, Iowa

  • START Research and Treatment

    Kansas City, Missouri

  • Salt Lake City VA Medical Center

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.